Pregnancy outcomes and risk factors analysis in patients with systemic lupus erythematous
Authors:
Open Access
- 22 July 2024
- journal article
- research article
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 24 (1) , 1-8
Abstract
Background: The management of systemic lupus erythematosus (SLE) during pregnancy remains a challenge currently. Identifying early predictors of adverse pregnancy outcomes in SLE patients can help to develop treatment plan and improve prognosis. The aim of this study is to explore the clinical and laboratory variables in the early pregnancy that can predict adverse neonatal and maternal outcomes, thereby facilitating the grading management of SLE. Methods: A retrospective analysis was conducted on 126 pregnant women with SLE who were admitted to Zhongnan Hospital of Wuhan University between January 2017 and December 2022. All enrolled patients were diagnosed (including newly diagnosed and previously diagnosed) during first trimester of pregnancy and their clinical records, laboratory results and pregnancy outcomes were reviewed. The association between the clinical and laboratory characteristics of patients at 12 gestational age and the adverse neonatal (ANOs) as well as maternal outcomes (AMOs) were analyzed. Results: A total of 117 live births (92.8%) were recorded in the study. ANOs occurred in 59 (46.8%) cases, including fetal loss in 9 cases (7.1%), preterm birth in 40 cases (31.7%), small for gestational (SGA) in 15 cases (11.9%), and complete heart block in 2 cases (1.5%). Univariate analysis showed that disease activity index (P < 0.0001), lupus nephritis (P = 0.0195), anti-SSB positivity (P = 0.0074) and hypocomplementemia (P = 0.0466) were related to ANOs. However, multivariate analysis showed that only disease activity during early pregnancy was an independent predictor for ANOs (OR = 7.053, 95% CI: 1.882 to 26.291, P = 0.004). In addition, 48 patients experienced AMOs during subsequent trimester, including 24 (19.0%) patients with disease flare and 23 (18.3%) patients with pre-eclampsia. Unplanned pregnancy (P = 0.010), active disease (P = 0.0004), new onset SLE (P = 0.0044) and lupus nephritis (P = 0.0009) were associated with AMOs in univariate analysis, while disease activity was identified as an independent risk factor for AMOs (OR = 2.553, 95% CI: 1.012–6.440, P = 0.047). Conclusion: Active disease in early pregnancy is associated with adverse pregnancy outcomes. For patients with high risk factor for ANOs and AMOs, more intensive treatment and follow-up should be a wise measure. Especially for those who suffer from active disease, they should be fully informed and given the option to terminate or continue their pregnancy.Keywords
Funding Information
- Knowledge Innovation Program of Wuhan City (2023020201020509)
- Medical Sci-Tech Innovation Platform of Zhongnan Hospital, Wuhan University (PTXM2024023)
- National Natural Science Foundation of China (82173909)
This publication has 33 references indexed in Scilit:
- Pregnancy rates and perinatal outcomes in women with systemic lupus erythematosus: data from the Korean national health claims databaseClinical Rheumatology, 2020
- Predictive factors for flares of established stable systemic lupus erythematosus without anti-phospholipid antibodies during pregnancyThe Journal of Maternal-Fetal & Neonatal Medicine, 2020
- Hypertensive disorders of pregnancy associated with adverse pregnant outcomes in patients with systemic lupus erythematosus: a multicenter retrospective studyClinical Rheumatology, 2019
- Pregnancy complicated by systemic lupus erythematosus and its outcome over 10 yearsJournal of Obstetrics and Gynaecology, 2018
- Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancyClinical Rheumatology, 2012
- Pregnancy and Systemic Lupus Erythematosus: Review of Clinical Features and Outcome of 51 Pregnancies at a Single InstitutionClinical Reviews in Allergy & Immunology, 2009
- The Hopkins Lupus Pregnancy Center: Ten Key Issues in ManagementRheumatic Disease Clinics of North America, 2007
- Hydroxychloroquine in lupus pregnancyArthritis & Rheumatism, 2006
- The impact of increased lupus activity on obstetric outcomesArthritis & Rheumatism, 2005
- Frequency of lupus flare in pregnancy: The hopkins lupus pregnancy center experienceArthritis & Rheumatism, 1991